Department of Immunology, Faculty of Medicine,
Imperial College London, Hammersmith Campus, London, UK.
Dr. Pillai is a renowned scientist in the field of oncology and is currently working as a Senior Scientist at the world famous Imperial College at London. He has more than 20 years of experience in the field of cancer research. He was one of the pioneers to show the therapeutic value of curcumin and suggested that curcumin may be used as a potential anticancer agent that can be employed to kill the lung cancer cells. He has acquired vast and diverse working experience by working at various institutes and industries in different countries including India, USA and UK. In addition, Dr. Pillai has served as chair of Ealing Hospital PPIF (London), Chief Editor/Executive Editor/member of editorial board of different scientific journals and Governor of different schools in USA and UK. He is currently advising the GIOSTAR team to study the cancer stem cell and trying to develop an agent which can manipulate the cancer stem cell to cure several cancers.